Confirmation value of Western blotting in detecting anti-treponema pallidum specific antibodies with suspicious results

Siqi Xu, Hongsheng Li, Xiaoyan Wu, Jianwei Guo, Jiaoli Zhang, Xu-Qi HuEuropean 2022 · DOI

TL;DR

When standard syphilis screening tests (ELISA and TPPA) yield conflicting results, Western blotting (WB) acts as the essential "tie-breaker." This study demonstrates that WB is critical for resolving inconsistent clinical samples, preventing both missed diagnoses and unnecessary treatments.

What Problem Does This Paper Address?

Syphilis diagnosis is notoriously tricky because it relies heavily on laboratory serological tests rather than direct pathogen detection. Clinicians typically use a two-step approach: a highly sensitive screening test (like ELISA) followed by a highly specific confirmatory test (like TPPA).

However, these tests don't always agree. ELISA can produce false positives due to cross-reactivity, while TPPA can yield false negatives or "reserved" (inconclusive) results due to subjective interpretation or antigen selection. When these results clash, clinicians face a dilemma: is the patient truly infected? This paper evaluates whether Western blotting—a more complex but highly detailed protein-separation technique—is a necessary third step to resolve these "suspicious" cases.

Methods

The researchers conducted a retrospective analysis of over 100,000 clinical samples. Their workflow followed a specific logic:

  1. Primary Screening: All samples were screened using ELISA.
  2. Retesting: Samples that were ELISA-positive, or ELISA-negative but showed visible color changes on the test plate (chromogeny), were retested using TPPA.
  3. The "Tie-Breaker": Any sample where ELISA and TPPA disagreed (e.g., ELISA+/TPPA- or ELISA-/TPPA+) was subjected to Western blotting (WB) for both IgG and IgM antibodies.

The study used the Chi-square test to determine if the differences between these diagnostic methods were statistically significant.

Datasets

The study utilized a massive real-world dataset from the Second Hospital of Jiaxing, China:

  • Total Screened: 106,757 anti-TP (Treponema pallidum) specimens collected between August 2018 and December 2019.
  • Retest Group: 3,972 samples were retested by TPPA.
  • Inconsistent Group: 163 specific serum samples that showed conflicting results between ELISA and TPPA served as the primary focus for WB evaluation.

Key Insights and Ideas

  • The "Visible" Negative: One of the most striking findings was that samples with an ELISA S/CO (Signal-to-Cutoff) ratio of less than 1.0 (technically negative) but with visible color on the plate often turned out to be positive. In fact, 22 out of 29 such "negative" samples were confirmed positive by WB.
  • Biological Interference: The authors investigated why these inconsistencies happen. They found that in many cases, patients had elevated levels of tumor markers (like ferritin, PSA, or SCC) or rheumatoid factors. These proteins can interfere with standard assays, leading to the "suspicious" results that require WB to untangle.
  • The Value of "Suspicious" WB Results: WB itself can return a "suspicious" result (usually a single antigenic band). Retrospective follow-up showed that most of these "suspicious" cases eventually turned fully positive, suggesting that WB is sensitive enough to catch early-stage infections that other tests might miss or misidentify.

Key Results

  • Inconsistency Rate: Out of the retested samples, 4.1% (163/3,972) showed conflicting results between ELISA and TPPA.
  • WB as the Final Arbiter: Among those 163 inconsistent cases:
  • 93 (57.06%) were confirmed negative by WB.
  • 31 (19.02%) were confirmed positive by WB.
  • 39 (23.93%) were suspicious.
  • Statistical Significance: The difference in results between ELISA/TPPA and the WB confirmation was statistically significant ($P < 0.05$), proving that neither ELISA nor TPPA alone is sufficient when results are borderline.

Limitations and Future Work

The authors acknowledge a few constraints:

  • Retrospective Design: Because the study looked at past data, the researchers couldn't perform standardized follow-up testing on every patient to see how their antibody status evolved over time.
  • Sample Size: While the initial screening pool was huge, the final "inconsistent" group (163 samples) is relatively small.
  • Future Directions: The study suggests a need for more longitudinal research specifically on "suspicious" WB results to determine the exact rate of seroconversion (when a patient officially tests positive). They also advocate for clinical laboratories to adopt WB as a standard protocol whenever ELISA and TPPA results are discordant.

Summary updated

Abstract

TPPA is an effective retest method for anti-TP antibody detection. If the results of anti-TP antibodies by ELISA and TPPA are inconsistent, it is necessary to use WB for confirmation. Trial registration This retrospective analysis is in accordance with the ethical guidelines of China and approved by the second hospital of Jiaxing (jxey-2018048).
BibTeX
@inproceedings{xu2022confirmation,
  author = {Siqi Xu and Hongsheng Li and Xiaoyan Wu and Jianwei Guo and Jiaoli Zhang and Xu-Qi Hu},
  title = {{Confirmation value of Western blotting in detecting anti-treponema pallidum specific antibodies with suspicious results}},
  booktitle = {European},
  year = {2022},
  doi = {10.1186/s40001-022-00633-y},
}
Figure